X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Pharma stocks lead markets higher 
(Fri, 8 Oct 09:30 am) 
 
The Indian markets have started today's session on a positive note. The benchmark indices opened below the breakeven mark but soon moved into the positive territory. Other key Asian markets are in the green with China (up 3.1%) leading the pack of gainers. The US markets ended lower by 0.2% yesterday.

Currently in India, heavyweights from the BSE-Sensex are trading strong with pharma majors attracting investors' interest. The BSE-Sensex is trading higher by around 31 points, while the NSE-Nifty is trading up by around 5 points. Buying interest is also being witnessed among mid and small cap stocks as the BSE-Midcap and BSE-Smallcap indices are trading higher by 0.4% and 0.6% respectively. The rupee is trading at 44.32 to the US dollar.

Energy stocks have opened the day on a strong note. Gainers here include Indian Oil and HPCL. As per a leading business daily, GAIL has placed orders worth Rs 6.8 bn for laying a gas pipeline from Dabhol in Maharashtra to Bangalore in Karnataka. It is a 1,400 km gas transmission project, which was approved by the company's board in June 2009 at an estimated cost of Rs 50 bn. The construction work will start by November 2010 and the pipeline will be ready by March 2012. The gas supplies are expected to begin by June 2012. The pipeline would have a transmission capacity of 16 million standard cubic meters per day of gas. The company has placed orders worth Rs 20 bn in the last three months for buying pipelines and laying operations for the project. Punj Lloyd is among the many suppliers for the project.

Pharma stocks have opened the day on a strong note. Gainers here include Torrent Pharma and Indoco Remedies. As per a leading business daily, Cadila Healthcare has received approval from the US health regulator to market certain high blood pressure treatment tablets in the US market. The company's subsidiary Zydus Cadila has received approvals for Losartan Potassium tablets and for Losartan Potassium and Hydrochlorothiazide tablets in various strengths. The company has already launched both products in the US market. Overall, Cadila Healthcare has 56 approvals and has filed for 113 abbreviated new drug applications ANDA's).

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Pharma stocks lead markets higher". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 23, 2017 (Close)

MARKET STATS